Insulet 

R$37.8
61
+R$0+0% Wednesday 19:50

統計

當日最高
37.8
當日最低
37.8
52週最高
37.8
52週最低
27.91
成交量
2
平均成交量
960
市值
-
市盈率
15.65
股息收益率
-
股息
-

即將到來

收益

31Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0.55
5.15
9.76
14.36
預期每股收益
4.4235645498
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 P2OD34.SA 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Show more...
首席執行官
Dr. James R. Hollingshead Ph.D.
員工
2300
國家
United States
ISIN
BRP2ODBDR009

上市公司